Contributor: SDOH-Sensitive Adherence Strategies for MA Health Equity Index Success
February 13th 2024The need for health equity spans the entire health care ecosystem, including the Medicare Advantage (MA) population. Neutralizing social determinants of health (SDOH) barriers, well-informed adherence strategies help MA plans navigate new CMS measurement frameworks, like the Health Equity Index.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Medicare Lawsuit Dismissed; COVID Isolation Guidelines; Millions Have Long COVID
February 13th 2024A ruling against Pharmaceutical Research and Manufacturers of America marks victory for efforts to lower health care costs; new guidelines align with flu and respiratory syncytial virus protocols; children and pregnant individuals are burdened with long-term health symptoms in the aftermath of COVID-19.
Read More
Durvalumab Consolidation Therapy Shows Promise in Elderly Patients With Stage III NSCLC
February 12th 2024Consolidation durvalumab led to comparable outcomes among older patients with unresectable stage III non–small cell lung cancer (NSCLC) vs a younger cohort with the same cancer; this patient population was underrepresented in the PACIFIC trial.
Read More
Meta-Analysis Highlights Differing CAR T Outcomes, Toxicities in Relapsed or Refractory DLBCL
February 12th 2024A real-world comparison of 2 chimeric antigen receptor (CAR) T-cell therapies—axicabtagene ciloleucel and tisagenlecleucel—suggests the former is associated with better efficacy but higher toxicity.
Read More
Dr David Eagle: CMS Reimbursement Cuts Encourage Trend of Independent Physician Exodus
February 12th 2024Over the past 20 years, Medicare physician pay has plummeted by 26% when adjusted for inflation, while hospital reimbursement has surged by 70%, prompting over 100,000 doctors to abandon independent practice for hospital or corporate employment since 2019.
Read More
Anti-VEGF Treatment Provides Long-Term Treatment in Diabetic Macular Edema
February 12th 2024Although corticosteroids were found to immediately improve best-corrected visual acuity and central macular thickness, anti–vascular endothelial growth factor (anti-VEGF) therapies had significant long-term advantages when treating diabetic macular edema.
Read More
Primary Care Diabetes Management May Also Reduce Risk of Dementia
February 12th 2024Participants in the Risk Assessment and Management Program-Diabetes Mellitus had reduced risks of developing all-cause dementia by 28%, Alzheimer disease by 15%, vascular dementia by 39%, and other or unspecified dementia by 29%.
Read More
Research Letter Shines Spotlight on Low Screening for HF Among Patients With T1D
February 10th 2024The findings follow endorsement of the screening measure from the American Diabetes Association, which recommended the practice to identify patients who have type 1 diabetes (T1D) who could benefit from targeted strategies to prevent symptomatic heart failure (HF).
Read More
In-House Biomarker Testing Shortens Time to Treatment Decision for mNSCLC
February 9th 2024This retrospective analysis compared molecular testing outcomes among newly diagnosed cases of metastatic non–small cell lung cancer (mNSCLC) from 2 periods: March 2017 to May 2019 and July 2019 to March 2021.
Read More
15-Year Analysis Shows Decrease in Ovarian Cancer Incidence, Incidence-Based Mortality
February 9th 2024The overall decline was mainly driven by decreased incidences of epithelial cancers in the ovaries, fallopian tubes, or peritoneum, as well as a decrease in the number of patients diagnosed with epithelial cancer, especially in advanced stages.
Read More
Hearing Impairment Disproportionately Affects Patients With SCD, Further Studies Required
February 9th 2024A cross-sectional comparative study demonstrated the increased prevalence of hearing impairment in children and adults with sickle cell disease (SCD) or sickle cell traits compared with healthy individuals.
Read More
Choroid Plexus Indicated in MS Pathology
February 9th 2024A longitudinal, observational study found that the choroid plexus, a network of blood vessels in each ventricle of the brain, plays a potential role in the neurodegenerative and chronic inflammatory process experienced by patients with relapsing remitting multiple sclerosis (MS).
Read More
Lowering Cardiometabolic Drug Costs May Improve Diabetes Health Outcomes
February 9th 2024Patients enrolled in a preventive drug list (PDL) benefit saw an 8.4% reduction in acute, preventable diabetes complication days, and PDL members residing in lower-income areas saw a 10.2% decrease compared with control members.
Read More
A wave of drug supply chain problems would occur if the FDA pulled cough and cold medications containing the active ingredient phenylephrine from shelves; lawmakers in 19 states are considering bills allowing medically assisted death; tuberculosis awareness is lagging as state and local health departments lack the resources to keep up with prevention and control efforts.
Read More
Study Finds AA Associated With Connective Tissue, Ocular Diseases and Vitamin D Deficiency
February 9th 2024Meta-analysis results identify high and low associations of various comorbidities like vitamin D deficiencies, ocular diseases, among others in patients with alopecia areata (AA), to promptly manage and improve treatment outcomes.
Read More
New Mexico Implements Mobile Crisis Intervention Teams With HHS Approval
February 8th 2024The mobile intervention teams mark a significant step forward in federal efforts to transform mental health services across the nation, as New Mexico becomes the 15th state to adopt this option under the American Rescue Plan.
Read More
Part D Drug Spending Cap Could Save Money for 1.5 Million Medicare Beneficiaries Next Year
February 8th 2024A provision in the Inflation Reduction Act will implement a $2000 out-of-pocket cap on Medicare beneficiaries’ prescription drug spending, which could save money for more than 1 million enrollees when it takes effect next year.
Read More